Direct Purchaser Settlement Class. The Plaintiffs have proposed a definition, subject to Court approval of the following Settlement Class: All persons or entities, and their successors and assigns, that directly purchased one or more of the Named Generic Drugs from one or more Defendants in the United States and its territories and possessions, at any time during the period from May 1, 2009 until December 31, 2019. Excluded from the Settlement Class are Defendants and their present and former officers, directors, management, employees, subsidiaries, or affiliates, judicial officers and their personnel, and all governmental entities. The Named Generic Drugs are set forth in Exhibit B (“Named Generic Drugs”). The Defendants are set forth in Exhibit C.
Direct Purchaser Settlement Class. The Settling Plaintiffs have proposed a definition, subject to Court approval, of the following Settlement Class: All persons or entities, and their successors and assigns, that directly purchased one or more of the Named Generic Drugs from one or more possessions, at any time during the period from May 1, 2009 until December 31, 2019. Excluded from the Settlement Class are Current and Former Defendants and their present and former officers, directors, management, employees, subsidiaries, or affiliates, judicial officers and their personnel, and all governmental entities. The Named Generic Drugs are set forth in Exhibit A Current and Former Defendants are set forth in Exhibit B.
